Health Canada Notice of Changes to the Special Access Program (SAP) for Medical Devices

Health Canada has announced important updates to the Special Access Program (SAP) for medical devices, introducing a new application form, a secure submission process, and mandatory procedural changes that will take effect on February 1, 2027. These changes are designed to streamline submissions, improve data security, reduce processing delays, and enhance consistency across applications. For healthcare professionals, manufacturers, importers, and regulatory affairs teams, understanding these changes is essential to maintaining compliant access to unlicensed and custom-made medical devices in Canada. 

Understanding the Health Canada Special Access Program for Medical Devices 

The Special Access Program allows authorized healthcare professionals to request access to certain unlicensed medical devices or custom-made medical devices for patients when conventional therapies have failed, are unavailable or are unsuitable, or when emergency treatment is required. The SAP serves as an important regulatory pathway for exceptional clinical situations where a licensed alternative device is not available. 

Under Canada’s Medical Devices Regulations, healthcare professionals may seek access to: 

• Unlicensed Class II, III, or IV medical devices 

• Custom-made medical devices designed for individual patients 

• Certain emergency-use devices 

• Limited quantities of devices intended for anticipated emergency situations 

Importantly, SAP authorization is not intended to serve as an alternative route to Canadian market authorization. Health Canada emphasizes that the program is designed for exceptional patient needs and is not a substitute for obtaining a Medical Device Licence or Investigational Testing Authorization. 

Key Changes Announced by Health Canada 

According to Health Canada’s August 24, 2026 notice, the department is modernizing the SAP application process to: 

• Reduce submission errors 

• Improve protection of sensitive patient and clinical information 

• Create a more consistent review process 

• Make SAP applications easier to complete and evaluate 

The modernization initiative includes two significant changes: 

1. A new accessible PDF application form. 

1. A new secure electronic submission method. 

These updates reflect broader trends in regulatory modernization and digital transformation across the Canadian healthcare regulatory landscape. 

New Accessible SAP Application Form 

One of the most significant updates is the introduction of a new accessible PDF application form for Special Access Medical Devices. Health Canada states that the form has been redesigned to improve usability and accessibility while supporting more efficient application processing. 

The new form is intended to: 

• Improve clarity for applicants 

• Meet federal accessibility standards 

• Ensure more complete and accurate applications 

• Support faster regulatory review and processing timelines 

Health Canada also recommends downloading and opening the application form using Adobe Acrobat Reader rather than completing it within a web browser. The form includes validation checks and interactive functionality that may not operate correctly in browser-based PDF viewers. 

For sponsors, proper completion of the SAP application remains critical. Health Canada continues to require detailed clinical justification supporting the request, including information regarding the patient’s condition, previous treatments, alternative therapies considered, expected benefits, and device-specific information. It’s also important to note that a healthcare professional must apply for SAP. A manufacturer does not submit an application but may work to support the healthcare professional with information on the device and can decide at what cost (if any) the medical device will be provided for. 

Secure Electronic Submission Becomes the Preferred Method 

In addition to the new form, Health Canada has introduced a secure electronic transmission tool for SAP medical device applications. The department indicates that the new submission method will: 

• Improve intake efficiency 

• Accelerate application processing 

• Better protect confidential patient information during transmission 

• Enhance overall security of submitted data 

Health Canada specifically recommends using the secure transmission platform as the preferred submission route. Fax submissions remain available during the transition period; however, organizations are encouraged to update internal workflows and move toward the new digital process as quickly as possible. 

For healthcare institutions, manufacturers, distributors, and consultants supporting SAP submissions, this change may require updates to standard operating procedures (SOPs), document management systems, compliance procedures, and staff training programs. 

Critical Deadline: February 1, 2027 

Perhaps the most important aspect of the notice is the implementation deadline. 

Health Canada has stated that beginning February 1, 2027, it will only accept SAP medical device applications submitted using the new application form and the submission methods identified in the notice. Older templates and outdated submission practices will no longer be accepted. 

Organizations that frequently use the Special Access Program should begin transition planning immediately. Recommended actions include: 

• Reviewing existing SAP processes 

• Updating internal templates and procedures 

• Training staff on the new application format 

• Testing the secure submission process 

• Revising quality management system documentation where applicable 

Failure to adapt before the deadline could result in delays to regulatory submissions and patient access. 

Common Reasons SAP Applications Are Delayed or Refused 

The Health Canada guidance documents provide valuable insight into common issues that can delay or prevent approval of SAP requests. Applications may be refused if: 

• A licensed alternative already exists 

• The risks outweigh the anticipated benefits 

• The patient’s need is not considered unique 

• Conventional treatment options remain available 

• Insufficient supporting information is provided 

• The application appears to circumvent medical device licensing requirements 

• The request is being made primarily for cost savings rather than medical necessity 

Additionally, Health Canada automatically rejects applications that are incomplete, illegible, or missing mandatory information. 

This highlights the importance of strong regulatory affairs support, thorough application preparation, and robust quality processes when preparing SAP submissions. 

Ongoing Compliance and Reporting Responsibilities 

Approval of an SAP request does not end regulatory responsibilities. 

Healthcare professionals who obtain access to a device through SAP must report serious adverse events associated with the device. Health Canada requires serious adverse events to be reported within 72 hours to both Health Canada and the manufacturer or importer. 

A serious adverse event may involve: 

• Device failure 

• Deterioration in device effectiveness 

• Inadequate instructions for use 

• Labelling deficiencies 

• Incidents resulting in death or serious deterioration of health, or that could do so if repeated 

These post-market obligations reinforce the importance of maintaining effective quality assurance systems, complaint handling processes, vigilance procedures, and regulatory reporting mechanisms. 

Final Thoughts 

Health Canada’s new Special Access Program application process for medical devices represents a meaningful modernization of regulatory operations. The introduction of an accessible PDF application form and secure electronic submission pathway is expected to improve efficiency, consistency, and data security while reducing administrative burden for applicants. 

Organizations involved in the Canadian medical device sector should begin preparing well in advance of the February 1, 2027 implementation deadline. Updating procedures, training personnel, and ensuring compliance with evolving Health Canada expectations will help avoid disruptions and support successful SAP submissions. 

For companies seeking expert guidance on Health Canada regulatory compliance, medical device licensing, Special Access Program applications, quality management systems, ISO 13485 and MDSAP compliance, proactive regulatory support can significantly improve submission quality, reduce risk, and accelerate access to critical medical technologies in the Canadian market.